SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-015378
Filing Date
2024-05-08
Accepted
2024-05-08 16:30:55
Documents
16
Period of Report
2024-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20240507_8k.htm   iXBRL 8-K 33282
2 EXHIBIT 99.1 ex_669422.htm EX-99.1 175096
7 logo01.jpg GRAPHIC 18167
  Complete submission text file 0001437749-24-015378.txt   377917

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dmac-20240508.xsd EX-101.SCH 3408
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20240508_def.xml EX-101.DEF 11028
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20240508_lab.xml EX-101.LAB 14741
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20240508_pre.xml EX-101.PRE 11133
20 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20240507_8k_htm.xml XML 2731
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 24926708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)